The finding that inhibition of MAOA can induce human adipocyte beiging in vivo suggests brain impenetrable, adipocyte favoring formulations of MAOA inhibitors as potential therapeutic agents in metabolic disease. Here, MAOA is linked to Other metabolic disease.